Bengaluru-based BacAlt Biosciences raised $2M in pre-seed funding from Avaana Capital and Lubrizol InnoVentures. Founded in 2024 by Shruti Kutmutia and Pranav Nair, the biotech startup makes biopolymers from post-harvest waste to reduce petrochemical use. The funds will expand R&D and production. Serving home care, personal care, and pharma sectors, BacAlt aims to position India as a bio-manufacturing hub within a $300B bioeconomy by 2030.
Trending
- Acko Taps Top Banks for H1 2027 IPO Target
- Fairdeal.Market Secures US$15M to Scale B2B Quick Commerce Across India
- India’s Startup IPO Surge: 48+ Listings Set to Unlock INR 50,000 Cr in 2026
- Indian Startup IPO Surge Expected by 2026 Amid Market Reset
- IIT Madras Director Unfazed by India’s AI Sovereignty Concerns
- Flipkart Bolsters Leadership with Key VP Appointments
- IEA Warns Current Oil Crisis Exceeds Past Shocks
- HomeEssentials Secures $7.7M to Fuel Retail Expansion


